Discover insights from Bill Andriopoulos, PhD, on Relfydess, a groundbreaking neuromodulator utilizing PEARL Technology for enhanced efficacy and safety.
Bill Andriopoulos, PhD
Advertisement
Bill Andriopoulos, PhD, is the Head of Global Medical Affairs at Galderma.
Articles by Bill Andriopoulos, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Dermatology Times
1
Phase 2b Analysis Shows Consistent Vitiligo Repigmentation With Ritlecitinib
2
FDA Grants Breakthrough Therapy Designation to Litifilimab for Cutaneous Lupus Erythematosus
3
Dual ITK/JAK3 Inhibition Shows Strong Preclinical Activity in Severe Alopecia Areata
4
Litifilimab Shows Early Skin Benefits in CLE
5